The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Each has an impressive history of share price performance and great prospects for further growth.
Intuitive Surgical continues to be one of the market's hottest stocks.
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Buying oversold stocks is not a question of one man's trash being another's treasure. In many cases, it's simply the ability to look at specific fundamental or technical indicators as a way to identif
Technical traders and technically-minded investors will rejoice after a look at the Intuitive Surgical NASDAQ: ISRG price chart. The market for this leading med-tech company has produced a strong rall
While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key me
A leading robotic surgery stock hit a new high on Friday and is in a buy zone. A telecom stock also hit a new high.
The Investment Committee discuss some of their stocks that are on the move.
Intuitive Surgical, Inc. ISRG Thursday reported upbeat earnings for its third quarter.
Shares of Intuitive Surgical (ISRG) hit an all-time high Friday, a day after the medical device maker posted better-than-expected results on more use of its da Vinci minimally invasive surgical device
ISRG's third-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales.
Major indexes faded late in Thursday's trading, with the Nasdaq Composite finishing up just .036%.
I reiterate a 'Sell' rating on Intuitive Surgical with a fair value of $350 per share due to its hefty valuation. The Da Vinci 5 robot rollout in mid-2025 is a major catalyst, with significant growth
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q3 2024 Earnings Conference Call October 17, 2024 4:30 PM ET Company Participants Brandon Lamb - Investor Relations Gary Guthart - Chief Executive Officer Dave
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE